Levocarnitine Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions


Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Levocarnitine is indicated in the treatment of primary systemic carnitine deficiency. In the reported cases, the clinical presentation consisted of recurrent episodes of Reye-like encephalopathy, hypoketotic hypoglycemia, and/or cardiomyopathy. Associated symptoms included hypotonia, muscle weakness and failure to thrive. A diagnosis of primary carnitine deficiency requires that serum, red cell and/or tissue carnitine levels be low and that the patient does not have a primary defect in fatty acid or organic acid oxidation (see CLINICAL PHARMACOLOGY). In some patients, particularly those presenting with cardiomyopathy, carnitine supplementation rapidly alleviated signs and symptoms. Treatment should include, in addition to carnitine, supportive and other therapy as indicated by the condition of the patient.

Levocarnitine is also indicated for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency.


There is currently no drug history available for this drug.

Other Information

Levocarnitine is a carrier molecule in the transport of long-chain fatty acids across the inner mitochondrial membrane.

The chemical name of levocarnitine is 3-carboxy-2(R)-hydroxy-N,N,N-trimethyl-1-propanaminium, inner salt. Levocarnitine is a white crystalline, hygroscopic powder. It is readily soluble in water, hot alcohol, and insoluble in acetone. The specific rotation of levocarnitine is between -29° and -32°. Its chemical structure is:

Levocarnitine Structural Formula

Empirical Formula:C7H15NO3

Molecular Weight: 161.20

Each Levocarnitine Tablet USP contains 330 mg of levocarnitine and the inactive ingredients magnesium stearate, microcrystalline cellulose and povidone.

Levocarnitine Manufacturers

  • Hi-tech Pharmacal Co., Inc.
    Levocarnitine Tablet [Hi-tech Pharmacal Co., Inc.]
  • Teva Parenteral Medicines, Inc.
    Levocarnitine Injection [Teva Parenteral Medicines, Inc.]
  • Rising Pharmaceuticals, Inc.
    Levocarnitine Tablet [Rising Pharmaceuticals, Inc.]
  • Bedford Laboratories
    Levocarnitine Injection [Bedford Laboratories]
  • American Regent, Inc.
    Levocarnitine Injection, Solution [American Regent, Inc.]

Login To Your Free Account